Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Uridine Triphosphate Thio-analogues Inhibit Platelet P2Y12 Receptors and Aggregation

Version 1 : Received: 6 November 2016 / Approved: 8 November 2016 / Online: 8 November 2016 (10:23:48 CET)
Version 2 : Received: 28 December 2016 / Approved: 28 December 2016 / Online: 28 December 2016 (10:46:04 CET)

A peer-reviewed article of this Preprint also exists.

Gündüz, D.; Tanislav, C.; Sedding, D.; Parahuleva, M.; Santoso, S.; Troidl, C.; Hamm, C.W.; Aslam, M. Uridine Triphosphate Thio Analogues Inhibit Platelet P2Y12 Receptor and Aggregation. Int. J. Mol. Sci. 2017, 18, 269. Gündüz, D.; Tanislav, C.; Sedding, D.; Parahuleva, M.; Santoso, S.; Troidl, C.; Hamm, C.W.; Aslam, M. Uridine Triphosphate Thio Analogues Inhibit Platelet P2Y12 Receptor and Aggregation. Int. J. Mol. Sci. 2017, 18, 269.

Abstract

Platelet P2Y12 is an important ADP receptor that is involved in agonists-induced platelet aggregation and is an important target for the development of anti-platelet aggregation drugs. Here the effects of thio-analogues of uridine triphosphate (UTP) on ADP-induced platelet aggregation are characterised. Using human platelet rich plasma we demonstrate that UTP inhibits P2Y12 but not P2Y1 receptors and antagonises ADP-induced platelet aggregation in a conc.-dependent manner with an IC50 value of ~250 mM against ADP (10 mM). An 8-fold increase in the platelet inhibitory activity was observed with 2-thio analogue of UTP (2S-UTP) with an IC50 value of 30 mM. A 33-fold increase in anti-platelet aggregation activity was observed with 4-thio analogue (4S-UTP) with an IC50 value of 7.5 mM. However, a 3-fold decrease in activity was observed by introducing an isobutyl group at the 4S- position. A complete loss in anti-platelet aggregation activity was observed with thio-modification of gamma phosphate of the sugar moiety which yields an enzymatically stable analogue. The interaction of UTP analogues with P2Y12 receptors was further verified by P2Y12 receptor binding assay and cAMP assay. The novel data demonstrate for the first time that 2- and 4-thio analogues of UTP are potent P2Y12 receptor antagonists that can be useful candidates for therapeutic intervention.

Keywords

2S-UTP; 4S-UTP; P2Y12 receptors; ADP; platelet aggregation

Subject

Medicine and Pharmacology, Pharmacology and Toxicology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.